Videos
Harnessing Gamma Frequencies to Modulate Alzheimer Pathology: Ralph Kern, MD, MHSc
April 15th 2025The chief medical officer at Cognito Therapeutics provided a clinical overview on promising findings surrounding the company’s gamma sensory stimulation device in patients with Alzheimer disease. [WATCH TIME: 10 minutes]
Improving Timely ALS Diagnosis With the thinkALS Toolkit: Melody Schaeffer, PhD, MPH
April 14th 2025The senior director of mission programs at The ALS Association discussed how the thinkALS Toolkit can aid general neurologists in identifying and referring suspected cases more efficiently. [WATCH TIME: 5 minutes]
Building Community and Education Through the AMDAPP CME Conference: Kinsey McCartney, PA-C
April 13th 2025The physician assistant at UCSF Movement Disorder and Neuromodulation Center reflected on the value of AMDAPP in fostering professional connection, education, and patient-centered care among movement disorder APPs. [WATCH TIME: 3 minutes]
Exploring Noninvasive Brain Stimulation for Neurorehabilitation: Roy H. Hamilton, MD, MS, FAAN
April 10th 2025The professor of neurology at the University of Pennsylvania Perelman School of Medicine discussed the current research landscape, clinical challenges, and future directions for noninvasive neuromodulation techniques in neurorehabilitation. [WATCH TIME: 4 minutes]
Educating the Clinical Community on Differences in Alzheimer Diagnostic Criteria: Clifford Jack, MD
April 10th 2025The neuroradiologist at Mayo Clinic provided clinical insights on the controversy with two recently published Alzheimer criteria, with one diagnosing the disease based on biomarkers alone vs clinical symptoms. [WATCH TIME: 4 minutes]
The Key Role of Early and Balanced Blood Pressure Control in ICH Management: Kara R. Melmed, MD
April 9th 2025The clinical associate professor of neurology and neurosurgery at NYU Langone Health emphasized the importance of rapid, targeted blood pressure reduction and bundled care to improve outcomes in patients with intracerebral hemorrhage. [WATCH TIME: 4 minutes]
CGRP Therapies as Potential First-Line Migraine Preventive Treatment: Andrew Charles, MD
April 7th 2025The director of the UCLA Goldberg Migraine Program discussed the advantages, evidence base, and evolving payor support for CGRP-targeting therapies as potentially a first-line option in migraine prevention. [WATCH TIME: 5 minutes]
Assessing Investigational CT1812’s Impact on Tau, Amyloid, and Neurodegeneration: Mary Hamby, PhD
April 3rd 2025The vice president of research at Cognition Therapeutics gave clinical insight on several new analyses covering CT1812, an orally delivered small molecule oligomer antagonist, in patients with early-stage Alzheimer disease. [WATCH TIME: 5 minutes]
Management of Neurogenic Bladder
April 1st 2025Panelist discusses how, for managing neurogenic bladder, neurologists should focus on individualized treatment plans emphasizing bladder emptying schedules, antimuscarinic medications when indicated, and clean intermittent catheterization as needed. Regular monitoring of renal function, urinary tract infection prevention, and coordination with urologists are crucial. Patient education about lifestyle modifications and adherence to treatment regimens is essential for optimal outcomes.
Exploring Multimodal Approaches to Neural Regeneration: Kuldip Dave, PhD
March 31st 2025The senior vice president of research at The ALS Association talked about a multidisciplinary session presented at the 2025 MDA Conference that highlighted diverse strategies for neural repair, from pharmacological targets to noninvasive brain stimulation. [WATCH TIME: 6 minutes]
Insights into OPMD and Advancements in Genetic Research: Matthew Wicklund, MD
March 31st 2025The professor of neurology at the University of Texas Health Science Center San Antonio provided clinical insights on the genetic basis of oculopharyngeal muscular dystrophy, as well as the primary challenges in diagnosing and treating the condition. [WATCH TIME: 5 minutes]
Bridging Neurology and Ophthalmology in Multiple Sclerosis Research
March 31st 2025In this final episode, neurologists discuss the role of advanced imaging, like OCT, in diagnosing and managing MS, emphasizing the need for further research to optimize its clinical application. [WATCH TIME: 2 minutes]
Challenges in Diagnosing Optic Neuritis in MS and MOGAD
March 30th 2025A pair of neurologists provide clinical insight on the difficulties with identifying and differentiating optic neuritis in various autoimmune conditions like multiple sclerosis and neuromyelitis optica spectrum disorder. [WATCH TIME: 4 minutes]
Educating the Clinical Community on Changes to MS Diagnostic Criteria
March 29th 2025In this third episode, experts delve into the evolving role of optic neuritis and the central vein sign in refining multiple sclerosis diagnosis, highlighting their significance in distinguishing MS from other conditions and ensuring accurate patient care. [WATCH TIME: 3 minutes]
Impact of Optic Nerve Inclusion on Early MS Diagnosis and Treatment
March 28th 2025Panelists explore the impact of including optic nerve involvement in the diagnostic criteria for multiple sclerosis, highlighting how this revision leads to more definitive diagnoses and earlier initiation of treatment for patients at high risk. [WATCH TIME: 2 minutes]
